Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Shuttle Pharmaceuticals dismisses auditor Forvis Mazars after material weaknesses disclosed

Negative Impact 4 of 5 leadership Written later

Shuttle Pharmaceuticals Holdings dismissed Forvis Mazars, LLP as its independent registered public accounting firm, effective after the filing of its Form 10-Q for the quarter ended September 30, 2026. The filing says the company has not yet engaged a replacement, and it cites multiple previously disclosed material weaknesses in internal control over financial reporting, which the company says were discussed with Forvis Mazars.

Key points

  • Audit Committee and full Board approved the dismissal of Forvis Mazars on October 16, 2026.
  • Forvis Mazars's reports for fiscal 2025 and 2024 included an explanatory paragraph on substantial doubt about the company's ability to continue as a going concern.
  • The company reports four material weaknesses, including limited accounting policies, insufficient review and segregation of duties, and information technology general control findings.
  • No successor auditor had been engaged as of the filing date; Forvis Mazars's letter is dated October 21, 2026 and filed as Exhibit 16.1.

The filing

CompanyShuttle Pharmaceuticals Holdings, Inc. (SHPH)
Form8-K, current report
Filed with the SECOct 22, 2026, 4:30 PM ET
Accession number0001493152-26-048112

Items reported: 4.01 Auditor Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.